Biological Safety Testing Products and Services Market Size Worth $11.16 Billion By 2032 | CAGR: 11.0%

The global biological safety testing products and services market size is expected to reach USD 11.16 billion by 2032, according to a new study by Polaris Market Research. The report “Biological Safety Testing Products and Services Market Share, Size, Trends, Industry Analysis Report, By Product (Reagents & Kits, Instruments, Services); By Test Type; By Application; By Region; Segment Forecast, 2024 - 2032” gives a detailed insight into current market dynamics and provides analysis on future market growth.

The growth of the biological safety testing products and services market is attributable to the rising innovations in new therapies in the healthcare industry. The increasing number of patients with cancer, cardiology, kidney, and liver health problems is forcing researchers and government agencies to step in and invest in cell and gene therapies. As an example, Rapport Therapeutics raised another $150 million to focus on the development of brain drugs.

As researchers innovate new therapies and drugs, there will be a huge demand for pharmaceutical settings to test the medicine for societal use. In the development and evaluation of pharmaceutical products, there is a need for biological safety testing of products and services.

The ongoing strategic expansion activities by the major players are contributing to the enlargement of the market for biological safety testing products and services. For instance, in November 2023, Merck expanded its new biologics testing center with the addition of 1,500 square meters to the lab in Shanghai.

Do you have any questions? Would you like to request a sample or make an inquiry before purchasing this report? Simply click the link below: https://www.polarismarketresearch.com/industry-analysis/biologics-safety-testing-market/request-for-sample

Countries are working to regulate the healthcare industry through the enforcement of stringent regulations on monitoring the safety of pharmaceutical products. In January 2023, Pluri unveiled its new cell therapy contract development and manufacturing organization division to provide cell therapy development services. Governments are stepping forward to promote the healthcare industry through strategic planning. For instance, in September 2023, the Belgium firm announced the establishment of a biopharmacy services campus at Genome Valley in Hyderabad.

Collaborations and partnerships among the key players are expanding the potential for monitoring or evaluating developments in the pharmaceutical space. In January 2024, Cherwell Laboratories, a microbiology solutions company, joined forces with AnalytiChem Group.

Biological Safety Testing Products and Services Market Report Highlights

• The Reagents & Kits segment is anticipated to witness the highest growth due to its ready-to-use testing ability.
• Vaccine segment accounted for the largest share owing to the increasing innovations in cell and gene therapies.
• The endotoxin tests segment held the larger share due to its potential to promote patient safety.
• Asia Pacific is projected to register the fastest growth during the forecast period, attributable to the growing investments in the pharmaceutical space.
• The global players include Agilent Technologies, Inc., Almac Group, Associates of Cape Cod, Inc., BioMérieux SA, & Bio-Rad Laboratories, Inc.

Polaris Market Research has segmented the biological safety testing products and services market report based on product, test type, application, and region:

Biological Safety Testing Products and Services, Product Outlook (Revenue - USD Billion, 2019 - 2032)

• Reagents & Kits
• Instruments
• Services

Biological Safety Testing Products and Services, Test Type Outlook (Revenue - USD Billion, 2019 - 2032)

• Vaccines & Therapeutics
• Blood & Blood-based Products
• Gene Therapy
• Tissue & Tissue-based Products
• Stem Cell

Biological Safety Testing Products And Services, Application Outlook (Revenue - USD Billion, 2019 - 2032)

• Endotoxin Tests
• Sterility Tests
• Cell Line Authentication & Characterization Tests
• Bioburden Tests
• Adventitious Agent Detection Tests
• Residual Host Contamination Detection Tests
• Others

Biological Safety Testing Products And Services, Regional Outlook (Revenue - USD Billion, 2019 - 2032)

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Netherlands
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Malaysia
• Latin America
  • Argentina
  • Brazil
  • Mexico
• Middle East & Africa
  • UAE
  • Saudi Arabia
  • Israel
  • South Africa

Biological Safety Testing Products and Services Market Report Scope